[Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx].
Yomi
J
J
Fouda
A
A
Fossi
A
A
Bejanga
B
B
D000293:Adolescent; D000328:Adult; D002277:Carcinoma / Q000276:immunology* / Q000473:pathology / Q000532:radiotherapy; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000276:immunology* / Q000473:pathology / Q000532:radiotherapy; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D012699:Serology
Intérêt de la sérologie du virus d'Epstein-Barr au cours de la radiothérapie du carcinome indifférencié du nasopharynx.